Drug intelligence / Profile preview

Asthom

Development stage
Unknown
Lead developer
Taj Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

**Asthom** is a Taj Pharma fixed-dose oral bronchodilator product containing **salbutamol sulfate** and **anhydrous theophylline**. Standard Asthom tablets contain salbutamol 2 mg plus theophylline 100 mg; Asthom syrup contains salbutamol 1 mg plus theophylline 50 mg per 5 mL. Salbutamol is a short-acting beta-2 adrenergic receptor agonist that relaxes bronchial smooth muscle, while theophylline is a methylxanthine bronchodilator with phosphodiesterase-inhibitory and adenosine-receptor-antagonist activity. Taj Pharma identifies Asthom for asthma, particularly where bronchodilation with more than one drug class is required. ([tajpharma.com](https://tajpharma.com/asthom-taj-products.htm))

Brand names
Asthom
02

Targets

ADOR (Adenosine receptors)PDE (Phosphodiesterase family)ADRB2 (β2)

Beyond the preview

Go deeper on Asthom.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Asthom.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call